Alain Hendlisz

The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer

Marianne Paesmans, Darius Razavi, D. Razavi, 2012, Autonomic Neuroscience.

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).

Karin Haustermans, Simone Mathoulin-Pélissier, Julien Taieb, 2014, European journal of cancer.

Prognostic Values of Galectin-3 and the Macrophage Migration Inhibitory Factor (MIF) in Human Colorectal Cancers

Robert Kiss, Isabelle Salmon, Christine Decaestecker, 2003, Modern Pathology.

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Marc Peeters, Bart Neyns, E. Van Cutsem, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection and Characterization of Tumor Changes in 18F-FDG PET Patient Monitoring Using Parametric Imaging

Irène Buvat, Patrick Emonts, Hatem Necib, 2011, The Journal of Nuclear Medicine.